Search results
Results from the WOW.Com Content Network
Resting platelets maintain active calcium efflux via a cyclic AMP-activated calcium pump. Intracellular calcium concentration determines platelet activation status, as it is the second messenger that drives platelet conformational change and degranulation. Endothelial prostacyclin binds to prostanoid receptors on the surface of resting platelets.
P-selectin is a type-1 transmembrane protein that in humans is encoded by the SELP gene. [5]P-selectin functions as a cell adhesion molecule (CAM) on the surfaces of activated endothelial cells, which line the inner surface of blood vessels, and activated platelets.
Laboratory tests might include: full blood count, liver enzymes, renal function and erythrocyte sedimentation rate. [citation needed] If the cause for the high platelet count remains unclear, bone marrow biopsy is often undertaken, to differentiate whether the high platelet count is reactive or essential. [citation needed]
Tests in platelet rich plasma (close to real conditions in the body, but restrictions as to the terms of work), Tests in whole blood (the most adjusted to human physiology; the test can be started immediately; but the least convenient due to terms of blood storage and difficulties of the results' interpretation).
Clotting time is a general term for the time required for a sample of blood to form a clot, or, in medical terms, coagulate.The term "clotting time" is often used when referring to tests such as the prothrombin time (PT), activated partial thromboplastin time (aPTT or PTT), activated clotting time (ACT), thrombin time (TT), or Reptilase time.
A thrombin generation assay (TGA) or thrombin generation test (TGT) is a global coagulation assay (GCA) and type of coagulation test which can be used to assess coagulation and thrombotic risk. [ 1 ] [ 2 ] [ 3 ] It is based on the potential of a plasma to generate thrombin over time, following activation of coagulation via addition of ...
Bleeding time is a medical test done to assess the function of a person's platelets. It involves making a patient bleed, then timing how long it takes for them to stop bleeding using a stopwatch or other suitable devices. The term template bleeding time is used when the test is performed to standardized parameters.
Multiplate multiple electrode aggregometry (MEA) is a test of platelet function in whole blood. [1] [2] The test can be used to diagnose platelet disorders, [3] [4] [5] monitor antiplatelet therapy, [6] and is also investigated as a potential predictor of transfusion requirements and bleeding risk in cardiac surgery. [7]